BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kesselheim AS, Outterson K. Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals. Health Affairs 2010;29:1689-96. [DOI: 10.1377/hlthaff.2009.0439] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yeh HS, Weng BC, Lien TF. Effects of Chinese traditional herbal medicine complex supplementation on the growth performance, immunity and serum traits of pigs. Anim Sci J 2011;82:747-52. [PMID: 22111630 DOI: 10.1111/j.1740-0929.2011.00897.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
2 Laxminarayan R, Powers JH. Antibacterial R&D incentives. Nat Rev Drug Discov 2011;10:727-8. [PMID: 21959280 DOI: 10.1038/nrd3560] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
3 Rejman D, Rabatinová A, Pombinho AR, Kovačková S, Pohl R, Zbornı́ková E, Kolář M, Bogdanová K, Nyč O, Šanderová H, Látal T, Bartůněk P, Krásný L. Lipophosphonoxins: New Modular Molecular Structures with Significant Antibacterial Properties. J Med Chem 2011;54:7884-98. [DOI: 10.1021/jm2009343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
4 Burris SC, Anderson ED. Making the case for laws that improve health: the work of the Public Health Law Research National Program Office. J Law Med Ethics 2011;39 Suppl 1:15-20. [PMID: 21309889 DOI: 10.1111/j.1748-720X.2011.00558.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Bhatti T, Lum K, Holland S, Sassman S, Findlay D, Outterson K. A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All. J Law Med Ethics 2018;46:59-65. [PMID: 30146959 DOI: 10.1177/1073110518782916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
6 Outterson K, Powers JH, Seoane-vazquez E, Rodriguez-monguio R, Kesselheim AS. Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009. J Law Med Ethics 2013;41:688-96. [DOI: 10.1111/jlme.12079] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 32.0] [Reference Citation Analysis]
7 Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013;8:769-783. [PMID: 23701332 DOI: 10.2217/fmb.13.47] [Cited by in Crossref: 406] [Cited by in F6Publishing: 337] [Article Influence: 45.1] [Reference Citation Analysis]
8 Burris S. Law in a social determinants strategy: a public health law research perspective. Public Health Rep 2011;126 Suppl 3:22-7. [PMID: 21836733 DOI: 10.1177/00333549111260S305] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sertkaya A, Jessup A, Wong HH. Promoting Antibacterial Drug Development: Select Policies and Challenges. Appl Health Econ Health Policy 2017;15:113-8. [PMID: 27601239 DOI: 10.1007/s40258-016-0279-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Amer A, Hamdy B, Mahmoud D, Elanany M, Rady M, Alahmadi T, Alharbi S, AlAshaal S. Antagonistic Activity of Bacteria Isolated from the Periplaneta americana L. Gut against Some Multidrug-Resistant Human Pathogens. Antibiotics (Basel) 2021;10:294. [PMID: 33799712 DOI: 10.3390/antibiotics10030294] [Reference Citation Analysis]
11 Riaz H, Godman B, Hussain S, Malik F, Mahmood S, Shami A, Bashir S. Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future: Bisphosphonates and antibiotics in Pakistan. Journal of Pharmaceutical Health Services Research 2015;6:111-21. [DOI: 10.1111/jphs.12091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
12 Chen Q, Fan X, Zhu D, An X, Su J, Cui L. Effect of biochar amendment on the alleviation of antibiotic resistance in soil and phyllosphere of Brassica chinensis L. Soil Biology and Biochemistry 2018;119:74-82. [DOI: 10.1016/j.soilbio.2018.01.015] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
13 Choi DW, Armitage R, Brady LS, Coetzee T, Fisher W, Hyman S, Pande A, Paul S, Potter W, Roin B, Sherer T. Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugs. Neuron 2014;84:554-63. [PMID: 25442934 DOI: 10.1016/j.neuron.2014.10.027] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
14 Belay DG, Jensen JD. ‘The scarlet letters’: Information disclosure and self-regulation: Evidence from antibiotic use in Denmark. Journal of Environmental Economics and Management 2020;104:102385. [DOI: 10.1016/j.jeem.2020.102385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Liu M, Yuan B, Jin X, Zhu M, Xu H, Xie G, Wang Z, Zhang X, Xu Z, Li B, Huang Y, Lv Y, Wang W. Citric Acid Promoting B Lymphocyte Differentiation and Anti-epithelial Cells Apoptosis Mediate the Protective Effects of Hermetia illucens Feed in ETEC Induced Piglets Diarrhea. Front Vet Sci 2021;8:751861. [PMID: 34917669 DOI: 10.3389/fvets.2021.751861] [Reference Citation Analysis]
16 Grant A, Parveen S, Schwarz J, Hashem F, Vimini B. Reduction of Salmonella in ground chicken using a bacteriophage. Poult Sci 2017;96:2845-52. [PMID: 28371846 DOI: 10.3382/ps/pex062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
17 Fürst J, Čižman M, Mrak J, Kos D, Campbell S, Coenen S, Gustafsson LL, Fürst L, Godman B. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Review of Anti-infective Therapy 2014;13:279-89. [DOI: 10.1586/14787210.2015.990381] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
18 Martínez JL, Coque TM, Baquero F. What is a resistance gene? Ranking risk in resistomes. Nat Rev Microbiol 2015;13:116-23. [PMID: 25534811 DOI: 10.1038/nrmicro3399] [Cited by in Crossref: 406] [Cited by in F6Publishing: 348] [Article Influence: 50.8] [Reference Citation Analysis]
19 Outterson K, Mcdonnell A. Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy. Health Affairs 2016;35:784-90. [DOI: 10.1377/hlthaff.2015.1139] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
20 Alt LM, Iverson AN, Soupir ML, Moorman TB, Howe A. Antibiotic resistance gene dissipation in soil microcosms amended with antibiotics and swine manure. J Environ Qual 2021;50:911-22. [PMID: 33982299 DOI: 10.1002/jeq2.20240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, Smith R, Zorzet A, Cohn J, Pittet D, Daulaire N, Morel C, Rizvi Z, Balasegaram M, Dar OA, Heymann DL, Holmes AH, Moore LS, Laxminarayan R, Mendelson M, Røttingen JA. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet 2016;387:296-307. [PMID: 26603920 DOI: 10.1016/S0140-6736(15)00470-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 37] [Article Influence: 11.6] [Reference Citation Analysis]
22 Godman B, Fadare J, Kibuule D, Irawati L, Mubita M, Ogunleye O, Oluka M, Paramadhas BDA, Costa JDO, de Lemos LLP, Júnior AAG, Alrasheedy AA, Hassali MA, Saleem F, Huong T, Truter I. Initiatives Across Countries to Reduce Antibiotic Utilisation and Resistance Patterns: Impact and Implications. In: Arora G, Sajid A, Kalia VC, editors. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Cham: Springer International Publishing; 2017. pp. 539-76. [DOI: 10.1007/978-3-319-48683-3_24] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Long Y, Lin S, Zhu J, Pang X, Fang Z, Lin Y, Che L, Xu S, Li J, Huang Y, Su X, Wu D. Effects of dietary lysozyme levels on growth performance, intestinal morphology, non-specific immunity and mRNA expression in weanling piglets. Anim Sci J 2016;87:411-8. [PMID: 26419503 DOI: 10.1111/asj.12444] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
24 Zorzet A. Overcoming scientific and structural bottlenecks in antibacterial discovery and development. Ups J Med Sci 2014;119:170-5. [PMID: 24646118 DOI: 10.3109/03009734.2014.897277] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
25 Panova N, Zborníková E, Šimák O, Pohl R, Kolář M, Bogdanová K, Večeřová R, Seydlová G, Fišer R, Hadravová R, Šanderová H, Vítovská D, Šiková M, Látal T, Lovecká P, Barvík I, Krásný L, Rejman D. Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins. PLoS One 2015;10:e0145918. [PMID: 26716439 DOI: 10.1371/journal.pone.0145918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
26 Nathan C. Fresh approaches to anti-infective therapies. Sci Transl Med 2012;4:140sr2. [PMID: 22745440 DOI: 10.1126/scitranslmed.3003081] [Cited by in Crossref: 115] [Cited by in F6Publishing: 105] [Article Influence: 11.5] [Reference Citation Analysis]
27 Hassali MA, Kamil TKT, Yusof FAM, Alrasheedy AA, Yusoff ZM, Saleem F, Al-tamimi SK, Wong ZY, Aljadhey H, Godman B. General practitioners’ knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Review of Anti-infective Therapy 2015. [DOI: 10.1586/14787210.2015.1012497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
28 Merrett GL, Bloom G, Wilkinson A, MacGregor H. Towards the just and sustainable use of antibiotics. J Pharm Policy Pract 2016;9:31. [PMID: 27761263 DOI: 10.1186/s40545-016-0083-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
29 Garcia Reeves AB, Stearns SC, Trogdon JG, Lewis JW, Weber DJ, Weinberger M. Impact of California's mandate for antimicrobial stewardship programs on rates of methicillin-resistant Staphylococcus aureus and Clostridioides difficile infection in acute-care hospitals. Infect Control Hosp Epidemiol 2021;42:298-304. [PMID: 32998788 DOI: 10.1017/ice.2020.446] [Reference Citation Analysis]
30 Daughton CG, Ruhoy IS. Green pharmacy and pharmEcovigilance: prescribing and the planet. Expert Rev Clin Pharmacol 2011;4:211-32. [PMID: 22115404 DOI: 10.1586/ecp.11.6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
31 Renwick MJ, Brogan DM, Mossialos E. A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. J Antibiot (Tokyo) 2016;69:73-88. [PMID: 26464014 DOI: 10.1038/ja.2015.98] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
32 Degeling C, Mayes C, Lipworth W, Kerridge I, Upshur R. The political and ethical challenge of multi-drug resistant tuberculosis. J Bioeth Inq 2015;12:107-13. [PMID: 25630591 DOI: 10.1007/s11673-014-9595-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Littmann J, Viens AM. The Ethical Significance of Antimicrobial Resistance. Public Health Ethics 2015;8:209-24. [PMID: 26566395 DOI: 10.1093/phe/phv025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
34 Md Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Md Yusof FA, Godman B. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Review of Anti-infective Therapy 2015;13:665-80. [DOI: 10.1586/14787210.2015.1025057] [Cited by in Crossref: 106] [Cited by in F6Publishing: 90] [Article Influence: 15.1] [Reference Citation Analysis]
35 Raboisson D, Barbier M, Maigné E. How Metabolic Diseases Impact the Use of Antimicrobials: A Formal Demonstration in the Field of Veterinary Medicine. PLoS One 2016;11:e0164200. [PMID: 27716805 DOI: 10.1371/journal.pone.0164200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
36 Zhu Z, Song ZH, Cao LT, Wang Y, Zhou WZ, Zhou P, Zuo FY. Effects of traditional Chinese medicine formula on ruminal fermentation, enzyme activities and nutrient digestibility of beef cattle. Anim Sci J 2018;89:661-71. [PMID: 29327395 DOI: 10.1111/asj.12978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Towse A, Sharma P. Incentives for R&D for New Antimicrobial Drugs. International Journal of the Economics of Business 2011;18:331-50. [DOI: 10.1080/13571516.2011.584434] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
38 Zeng Y, Wang Z, Zou T, Chen J, Li G, Zheng L, Li S, You J. Bacteriophage as an Alternative to Antibiotics Promotes Growth Performance by Regulating Intestinal Inflammation, Intestinal Barrier Function and Gut Microbiota in Weaned Piglets. Front Vet Sci 2021;8:623899. [PMID: 33585620 DOI: 10.3389/fvets.2021.623899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Dutescu IA, Hillier SA. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study. Infect Drug Resist 2021;14:415-34. [PMID: 33574682 DOI: 10.2147/IDR.S287792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hollis A, Ahmed Z. The path of least resistance: paying for antibiotics in non-human uses. Health Policy 2014;118:264-70. [PMID: 25240271 DOI: 10.1016/j.healthpol.2014.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Huttner B, Samore M. Outpatient Antibiotic Use in the United States: Time to “Get Smarter”. Clinical Infectious Diseases 2011;53:640-3. [DOI: 10.1093/cid/cir449] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
42 Gould I. Coping with antibiotic resistance: the impending crisis. International Journal of Antimicrobial Agents 2010;36:S1-2. [DOI: 10.1016/s0924-8579(10)00497-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]